ArticleOncology letters2025
Triple-negative invasive lobular carcinoma presenting with synchronous gastric metastasis: A case report.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ovarian Metastasis from Invasive Lobular Carcinoma of the Breast: A 6-Case Series with Emphasis on Diagnostic Challenges and the Value of Biopsy.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Triple-negative invasive lobular carcinoma (TN-ILC) is a rare and highly aggressive subtype of breast cancer. The development of gastric metastases in breast cancer is extremely rare and typically occurs several years after initial diagnosis. The present case report describes a 68-year-old postmenopausal female patient who presented with TN-ILC with gastric metastases at initial diagnosis. This metastatic pattern is very rare and is often mistaken for primary gastric cancer, which poses a notable diagnostic challenge. Imaging and histopathological analyses confirmed typical TN-ILC features (estrogen receptor negative, progesterone receptor negative and HER-2 1+ positive) and revealed diffuse metastases to the gastric wall, brain, bone, adrenal glands, pleura and lymph nodes. Gastric metastases from breast cancer were further confirmed by immunohistochemical studies, including for GATA binding protein 3, Villin and cytokeratin 7/20. It is noteworthy that the patient exhibited no gastrointestinal symptoms, which could have led to a missed diagnosis. The present case underscores the significance of a comprehensive evaluation in metastatic breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.